BOAOVAX

BoaoVax is a clinical-stage biotechnology company based in Beijing, China, specializing in the development of innovative recombinant vaccines. The company utilizes its proprietary virus-like particle (VLP) technology platform to design and manufacture high-efficacy vaccines against infectious diseases. Its lead product candidate, BV-001, is a 9-valent HPV vaccine currently in Phase 3 clinical trials, aiming to address the significant demand for cervical cancer prevention. BoaoVax is also advancing a diverse pipeline that includes a 15-valent HPV vaccine, a recombinant COVID-19 vaccine, and a rotavirus vaccine. With a large-scale GMP-compliant manufacturing facility, the company is positioned to support both clinical development and future commercial supply.